Abstract
Catalase-peroxidase (KatG) is a dual functional enzyme with both catalase and peroxidase activity. KatGs protect aerobic microorganisms from oxidative damage through their high catalase activity, and in Mycobacterium tuberculosis (M.tb.) KatG's peroxidatic activity is central in converting the anti-tuberculosis (TB) pro-drug isoniazid (INH) into an active bactericidal molecule in vivo. There are several antibiotics currently in use to treat TB with INH being one of the first anti-TB agents. A central goal is to understand the catalytic function of M.tb. KatG in drug activation and how mutations in KatG found in INH-resistant strains interfere with this process. One of the most common INH-resistant M.tb. strains has the KatG[Ser315Thr] mutation, previously reported to cause narrowing of a substrate access channel. We have now solved the structure of another mutant [Asp137Ser], which shows enhanced INH-activation ascribed to an enlarged access channel. This study demonstrates that altering the dimensions of the bottleneck in the substrate access channel in KatG can impede or enhance INH peroxidation rates relative to the WT enzyme.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Acta Crystallographica Section A Foundations and Advances
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
